Ignite Creation Date:
2025-12-24 @ 4:13 PM
Ignite Modification Date:
2026-02-23 @ 8:08 PM
Study NCT ID:
NCT05826366
Status:
COMPLETED
Last Update Posted:
2025-06-03
First Post:
2023-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Imfinzi/Imjudo NSCLC Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - CEI/SCEI
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-02
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-30
Completion Date Type:
ACTUAL
First Submit Date:
2023-04-06
First Submit QC Date:
None
Study First Post Date:
2023-04-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-06-02
Last Update Post Date:
2025-06-03
Last Update Post Date Type:
ACTUAL